Literature DB >> 23361841

Role of the cmcH-ccaR intergenic region and ccaR overexpression in cephamycin C biosynthesis in Streptomyces clavuligerus.

Aslıhan Kurt1, Rubén Álvarez-Álvarez, Paloma Liras, Gülay Özcengiz.   

Abstract

The effect of the CcaR regulatory protein on expression of the cephamycin C gene cluster is studied. Quantitative reverse transcription PCR (qRT-PCR) expression analysis of the cephamycin biosynthesis genes in the ccaR-disrupted strain, S. clavuligerus ccaR::aph, revealed that in the absence of CcaR, the lat and cmcI genes expression was reduced 2,200- and 1,087-fold compared with the wild type. Expression of pcbAB-pcbC-cefD-cefE-cmcJ-cmcH and blp was 225- to 359-fold lower, while expression of pcbR-pbpA-bla and orf10 was only slightly affected if at all, indicating that resistance and regulatory genes are not under CcaR control as opposed to pathway biosynthetic genes. In the intergenic cmcH-ccaR region, a small messenger RNA (mRNA) overlaps with the cmcH transcription terminator. Deletion of 688 bp of the intergenic region results in a strain, S. clavuligerus ΔRI, still able to produce cephamycin C and clavulanic acid but at levels 30-40% lower than the parental strain. Therefore, specific sequences in the intergenic region upstream of ccaR enhance the expression of ccaR but are not essential for its expression. Strains containing an additional ccaR gene integrated in the chromosome, S. clavuligerus pSET-PC, or multiple copies of ccaR expressed from the PglpF promoter, S. clavuligerus pAK23, were constructed. Fermentations of the pAK23 strain resulted in a 6.1-fold increase in specific cephamycin C production relative to the wild type. In the same experiments, qRT-PCR analysis of the cephamycin biosynthesis genes showed a 5.1-fold increase in ccaR expression and similar increases in expression of lat and cmcI, while expression of other cluster genes were increased in the order of 2- to 3-fold.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23361841     DOI: 10.1007/s00253-013-4721-4

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  7 in total

1.  An integrative-omics analysis of an industrial clavulanic acid-overproducing Streptomyces clavuligerus.

Authors:  Aslıhan Kurt-Kızıldoğan; Gözde Çelik; Eser Ünsaldı; Servet Özcan; Şerife Ayaz-Güner; Gülay Özcengiz
Journal:  Appl Microbiol Biotechnol       Date:  2022-08-10       Impact factor: 5.560

2.  Homologous expression of lysA encoding diaminopimelic acid (DAP) decarboxylase reveals increased antibiotic production in Streptomyces clavuligerus.

Authors:  Çiğdem Otur; Aslıhan Kurt-Kızıldoğan
Journal:  Braz J Microbiol       Date:  2019-12-12       Impact factor: 2.476

3.  Elucidating the Regulatory Elements for Transcription Termination and Posttranscriptional Processing in the Streptomyces clavuligerus Genome.

Authors:  Soonkyu Hwang; Namil Lee; Donghui Choe; Yongjae Lee; Woori Kim; Yujin Jeong; Suhyung Cho; Bernhard O Palsson; Byung-Kwan Cho
Journal:  mSystems       Date:  2021-05-04       Impact factor: 6.496

4.  The CagRS Two-Component System Regulates Clavulanic Acid Metabolism via Multiple Pathways in Streptomyces clavuligerus F613-1.

Authors:  Jiafang Fu; Ronghuo Qin; Gongli Zong; Cheng Liu; Ni Kang; Chuanqing Zhong; Guangxiang Cao
Journal:  Front Microbiol       Date:  2019-02-14       Impact factor: 5.640

Review 5.  Clavulanic Acid Production by Streptomyces clavuligerus: Insights from Systems Biology, Strain Engineering, and Downstream Processing.

Authors:  Víctor A López-Agudelo; David Gómez-Ríos; Howard Ramirez-Malule
Journal:  Antibiotics (Basel)       Date:  2021-01-18

6.  The SCO4117 ECF Sigma Factor Pleiotropically Controls Secondary Metabolism and Morphogenesis in Streptomyces coelicolor.

Authors:  María T López-García; Paula Yagüe; Nathaly González-Quiñónez; Beatriz Rioseras; Angel Manteca
Journal:  Front Microbiol       Date:  2018-02-21       Impact factor: 5.640

7.  Streptomyces clavuligerus: The Omics Era.

Authors:  Paloma Liras; Juan F Martín
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.